NCT04394676View on ClinicalTrials.gov

The Impact of Low Pressure Pneumo in RARP II

NAUnknownINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions
Prostate Cancer
Interventions
PROCEDURE

Pressure applied during RARP

Patients will be randomly assigned to undergo RARP either at a pneumoperitoneum pressure of 12 mmHg (experimental) or 15mm Hg (standard technique).

Trial Locations (1)

49519

RECRUITING

Metro Health-University of Michigan Health, Wyoming

Sponsors
All Listed Sponsors
lead

Metro Health, Michigan

OTHER

NCT04394676 - The Impact of Low Pressure Pneumo in RARP II | Biotech Hunter | Biotech Hunter